文献速递复苏、休克与脓毒症儿科与产科急症

特定实验室生物标志物对预测儿童SIRS患者严重脓毒症的效用

Utility of specific laboratory biomarkers to predict severe sepsis in pediatric patients with SIRS.
PubMed 文献 · Am J Emerg Med · 2021-10-06
一句话结论在急诊SIRS患儿中,降钙素原、CRP、ESR和乳酸升高对预测24小时内严重脓毒症均特异但不敏感。

该回顾性队列研究纳入2018年6月至2019年6月急诊触发自动脓毒症警报(基于SIRS标准)且6小时内送检CRP、ESR、乳酸或降钙素原的1207例次就诊。主要结局为急诊处置后24小时内严重脓毒症,降钙素原AUC最高为0.62(95%CI 0.52-0.73);血培养阳性严重脓毒症中ESR和CRP的AUC分别为0.68(95%CI 0.47-0.89)和0.67(95%CI 0.53-0.81)。90%灵敏度时各标志物阈值均落在正常范围内;90%特异度时降钙素原2.72 ng/mL、CRP 16.79 mg/dL、ESR 79.5 mm/h、乳酸3.6 mmol/L。作者认为这些标志物升高对识别进展为严重脓毒症的SIRS患儿均特异但不敏感。

要点

  • 在急诊SIRS患儿中,降钙素原预测24小时内严重脓毒症的AUC最高,但也仅为0.62(95%CI 0.52-0.73)。
  • 预测血培养阳性严重脓毒症时,ESR的AUC为0.68(95%CI 0.47-0.89),CRP为0.67(95%CI 0.53-0.81)。
  • 要达到90%特异度,降钙素原阈值为2.72 ng/mL、CRP为16.79 mg/dL、ESR为79.5 mm/h、乳酸为3.6 mmol/L。
  • 要达到90%灵敏度,所有标志物的阈值均落在该实验室检查的正常范围内。
  • 作者认为CRP、ESR、乳酸和降钙素原升高对识别进展为严重脓毒症的SIRS患儿均特异但不敏感。

适用人群与场景

  • 2018年6月至2019年6月期间,急诊就诊时基于SIRS标准触发自动脓毒症警报、且在到达急诊6小时内送检CRP、ESR、乳酸或降钙素原中任一项的儿童患者。

诊断标准与关键阈值

  • 严重脓毒症定义为急诊处置后24小时内发生严重脓毒症。
  • 血培养阳性严重脓毒症定义为严重脓毒症且细菌培养阳性。
  • 90%特异度对应的阈值:降钙素原2.72 ng/mL,CRP 16.79 mg/dL,ESR 79.5 mm/h,乳酸3.6 mmol/L。

研究设计与关键结果

  • 研究类型为回顾性队列研究;研究期间共61195例次急诊就诊,其中4349/61195(7.1%)触发自动脓毒症警报。
  • 4349例次触发警报的就诊中,1207/4349(27.8%)在到达急诊6小时内送检了候选生物标志物之一,被纳入研究。
  • 1207例次纳入就诊中,100/1207(8.3%)在到达后24小时内符合严重脓毒症标准;100例严重脓毒症中41/100(41%)为培养阳性。
  • 降钙素原识别严重脓毒症的AUC最高,为0.62(95%CI 0.52-0.73)。
  • ESR和CRP识别培养阳性脓毒症的AUC分别为0.68(95%CI 0.47-0.89)和0.67(95%CI 0.53-0.81)。
  • 在90%灵敏度下检测严重脓毒症时,所有生物标志物阈值均落在该实验室检查的正常范围内。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,CRP、ESR、乳酸和降钙素原升高对识别急诊SIRS患儿中进展为严重脓毒症者均特异但不敏感。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To identify the association between readily available laboratory biomarkers and the development of severe sepsis in children presenting to the emergency department (ED) with systemic inflammatory response syndrome (SIRS).

METHODS: In this retrospective cohort study, ED patient encounters from June 2018 to June 2019 that triggered an automated sepsis alert based on SIRS criteria were analyzed. Encounters were included if the patient had any of the following laboratory tests sent within 6 h of ED arrival: C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), lactic acid, and procalcitonin. For each of the biomarkers, a receiver operating characteristic (ROC) curve was created for our primary outcome, severe sepsis within 24 h of ED disposition, and our secondary outcome, severe sepsis with a positive bacterial culture. For each ROC curve, we calculated the area under the curve (AUC) with 95% confidence intervals (95% CI) and created cutoff points to achieve 90% sensitivity and 90% sensitivity for the primary and secondary outcomes.

RESULTS: During the study period, 4349/61,195 (7.1%) encounters triggered an automated sepsis alert. Of those, 1207/4349 (27.8%) had one of the candidate biomarkers sent within 6 h of ED arrival and were included in the study. A total of 100/1207 (8.3%) met criteria for severe sepsis within 24 h of arrival, and 41/100 severe sepsis cases (41%) were deemed culture-positive. Procalcitonin had the highest AUC for identifying severe sepsis [0.62 (95% CI 0.52-0.73)] while ESR and CRP had the highest AUC for culture-positive sepsis [0.68 (95% CI 0.47-0.89) and 0.67 (95% CI 0.53-0.81), respectively]. At 90% sensitivity for detecting severe sepsis, all of the biomarker threshold values fell within that laboratory test's normal range. At 90% specificity for severe sepsis, threshold values were as follows: procalcitonin 2.72 ng/mL, CRP 16.79 mg/dL, ESR 79.5 mm/h and lactic acid 3.6 mmol/L.

CONCLUSION: Our data indicate that CRP, ESR, lactic acid, and procalcitonin elevations were all specific, but not sensitive, in identifying children in the ED with SIRS who go on to develop severe sepsis.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Byler S, Baker A, Freiman E, et al. Utility of specific laboratory biomarkers to predict severe sepsis in pediatric patients with SIRS. Am J Emerg Med. 2021. PMID: 34879502. doi:10.1016/j.ajem.2021.09.081

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。